Leon L’Huillier – Chairman
Chairman, Leon L’Huillier has a respected track record as a business man in his roles as a Chairman or Director of Medical Research, health and road trauma organisations. He is currently Deputy Chairman of Australian Prostate Cancer Research. He is former Chairman of the Vision CRC at the University of NSW, the world’s leading centre for cornea and contact lens applied research.
Other Board appointments include being a former Chairman of the Australian Health Ministers Advisory Council, Chairman, the Royal Children’s Hospital, Brisbane and Director of the National Health and Medical Research Council. He is former Director of St. Vincent’s Hospital, Melbourne and the O’Brien Institute that carries out internationally recognised scientific research in the fields of Tissue Engineering and Vascular Biology. He was Chief of Health Department Victoria where he introduced a large number of reforms.
As Executive Chairman of Victoria’s Transport Accident Commission he developed and introduced the innovative TAC road safety campaigns, which reduced Victoria’s road toll by almost 50% in three years. He won a Cannes Golden Lion and received international recognition for his pioneering work. In private equity he has worked with major Australian firms including Macquarie Bank, Grant Samuel, Archer Capital, Ironbridge and Gresham.
A former Director and Audit Chairman of Woolworths Limited, Director of Challenge Bank and MLC Limited, Chairman, Lend Lease Investment Board and the Australian Prime Property Fund Limited. He is a former Director of Price Waterhouse Australian Policy Board. He has been a CEO of fast moving consumer goods (FMCG) companies.
Qualifications: MBA, (Chicago), MPhil, (London), BCom (Hons) (Melbourne), FAICD
Mario Gattino – CEO, Director
Mr Gattino is an internationally networked and award winning senior executive with 25+ years’ experience in pivotal ‘C’ suite leadership roles, realigning underperforming enterprises with comprehensive change leadership, crisis management and organisational turnaround expertise.
His experience is highly influenced by a distinguished 20 year career at Pfizer Inc. contributing to a long successful track record in commercialising drug and device products globally and growing sales in multiple markets including the USA, Europe and Asia. Taking on business critical international roles in complex commercial and sociopolitical environments, executing sophisticated corporate refocus, high-performance teambuilding and extensive stakeholder liaison of all major regulatory agencies (FDA,EMEA, TGA etc…) to deliver resounding profitability and viability.
Mr Gattino is a specialist in executive leadership and crisis management supported by high-caliber strategic planning and operational execution in complex project management, brand commercialisation, global portfolio execution, business development via M&A and licensing plus sophisticated stakeholder management.
Qualifications: MBA (Distinction) and Graduate Diploma in Management, University of New South Wales (Australian Graduate School of Management), Bachelor’s Degree Applied Science (Medical Administration) La Trobe University, Graduate (GAICD) Australian Institute of Company Directors, Executive Leadership Program, Harvard Business School.
John Ribot de Bresac – Independent Non-Executive Director
John has extensive experience and a strong record of achievement as a senior executive across consumer facing businesses in the sport, leisure and hospitality industries including in strategy development and implementation. Following a distinguished sports career where he received the Australian Sports Medal, he was instrumental in the establishment of the Brisbane Broncos and Melbourne Storm, in executive Director roles, and as chairman of the Brisbane Roar. Currently John serves as Director of Victorian Major Events Company, executive chairman of Queensland Clubs Management (QCM), and owns hospitality venues throughout Queensland.
Scientific & Medical Advice
Respiri has worked with a number of globally respected physicians and scientists including, but not limited to:
Professor Noam Gavriely
An international authority on pulmonary acoustics, Prof Gavriely has extensively published on breath sound monitoring over the last 25 years and holds multiple patents on phonopneumography and other aspects of breath sound monitoring.
Professor Simon Godfrey
Emeritus Professor Pediatrics at the Hadassah-Hebrew University, Jerusalem, Prof Godfrey’s main research interests are in pediatric pulmonary physiology and application of novel investigative techniques for the diagnosis and management of pediatric pulmonary disease. He has published over 190 original papers and 16 books.
Professor Zahra Moussavi
Director, Biomedical Engineering Program Professor & Canada Research Chair University of Manitoba, Prof Moussavi specialises in sleep apnea, respiratory sounds analysis and Alzheimer’s diagnosis and treatment. She has published more than 180 papers.
Dr David Danztker
An internationally recognised expert in pulmonary medicine and critical care Dr Dantzker has served on the faculty and in leadership positions of four major research-oriented medical schools and authored or co-authored 130 research papers and five textbooks. He is former Chair of the American Board of Internal Medicine, the largest physician certifying board in the US.
Dr Catherine Downes
Dr Downes is a General Practitioner who has practiced in London and Australia. She has been a Principal of several large medical centres in Queensland and currently practice in a Sydney CBD medical centre. Dr Downes has also served as a Government Medical Officer in Queensland and attended Magistrate, District and Supreme courts as an expert medical witness.